Moderna says FDA refuses to review its application for experimental flu shot

FDA intends to take action against non-FDA-approved GLP-1 drugs

Any application that can be written in a system language, eventually will be

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say